| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.20B | — | -6.3% |
| Cost of Revenue | $6.50B | — | -8.9% |
| R&D Expense | $36.0M | — | +5.9% |
| SG&A Expense | $411.0M | — | +2.5% |
| Operating Income | $239.0M | — | +109.6% |
| Pre-tax Income | $137.0M | — | +132.2% |
| Income Tax | -$2.0M | — | -105.6% |
| Net Income | $125.0M | — | -29.4% |
| EPS (Basic) | $0.38 | — | -29.6% |
| EPS (Diluted) | $0.38 | — | -29.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.63B | -23.5% | +41.1% |
| Short-term Investments | $1.47B | -27.6% | +26.5% |
| Inventory | $3.63B | +2.9% | -26.3% |
| Current Assets | $11.06B | +1.7% | -3.0% |
| Total Assets | $33.96B | -0.1% | -3.5% |
| Current Liabilities | $7.19B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$269.0M | — | +53.5% |
| Capital Expenditures | $269.0M | — | -44.3% |
| Investing Cash Flow | -$279.0M | — | +35.1% |
| Financing Cash Flow | -$236.0M | — | +56.9% |
| Free Cash Flow | -$538.0M | — | +49.3% |
| +15.2% |
| Long-term Debt | $11.23B | -7.4% | +5.9% |
| Stockholders' Equity | $10.04B | -0.4% | -17.8% |